Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Stock Short Interest Report for October

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the target of a significant growth in short interest in the month of October. As of October 30th, there was short interest totaling 30,112 shares, a growth of 4,554.1% from the October 15th total of 647 shares. Based on an average daily trading volume, of 125,394 shares, the short-interest ratio is presently 0.2 days.

Ono Pharmaceutical Stock Down 1.2%

Shares of Ono Pharmaceutical stock traded down $0.06 during trading on Tuesday, reaching $5.06. 41,051 shares of the company were exchanged, compared to its average volume of 38,511. Ono Pharmaceutical has a twelve month low of $4.17 and a twelve month high of $5.75. The business has a 50-day moving average price of $5.02 and a 200-day moving average price of $5.03.

About Ono Pharmaceutical

Ono Pharmaceutical Co., Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and commercialization of prescription medicines. The company focuses on areas including oncology, immunology, neurology and other serious diseases, with an emphasis on discovering therapies that address unmet medical needs. Ono is best known for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb. Opdivo is used in multiple cancer indications, depending on regulatory approval in individual markets.